September 6, 2015 /
Extended campaign by patients proves success for medicine that helps sufferers to walk
Sept 3, 2015 – The Health Service Executive has agreed to fund on a limited basis the cost of a drug that helps people with multiple sclerosis to walk.
The announcement that Fampridine (known commercially as Fampyra) is to be reimbursed under the State-funded drugs schemes follows a lengthy campaign by patients who says the drug has greatly aided their mobility.
The HSE says it is in the final stages of putting in place the arrangement around a “responder-based” reimbursement programme for Fampridine.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide
by signing up by clicking here
.=====================================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY
